|
Volumn 9, Issue 3, 2001, Pages 223-228
|
Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines
a a a a a |
Author keywords
Antihistamine; Blood brain barrier; CNS side effects; P glycoprotein; RBE4; Sedation
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
ASTEMIZOLE;
BASIC FIBROBLAST GROWTH FACTOR;
CARBON 14;
COLCHICINE;
DIPHENHYDRAMINE;
GLYCOPROTEIN P;
HISTAMINE H1 RECEPTOR;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HYDROXYZINE;
IMIPRAMINE;
MEPYRAMINE;
SEDATIVE AGENT;
SUCROSE;
TEMELASTINE;
TERFENADINE;
TRITIUM;
VERAPAMIL;
ANIMAL CELL;
ARTICLE;
BINDING AFFINITY;
BLOOD BRAIN BARRIER;
BRAIN CORTEX;
CENTRAL NERVOUS SYSTEM;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG PROTEIN BINDING;
DRUG STRUCTURE;
DRUG TARGETING;
DRUG UPTAKE;
ENDOTHELIUM CELL;
HYPOTHESIS;
IN VITRO STUDY;
LIPOPHILICITY;
NEUROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN INTERACTION;
PROTEIN TRANSPORT;
RAT;
SEDATION;
STRUCTURE ANALYSIS;
TOXICITY TESTING;
|
EID: 0034888307
PISSN: 1061186X
EISSN: None
Source Type: Journal
DOI: 10.3109/10611860108997930 Document Type: Article |
Times cited : (74)
|
References (21)
|